Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.040 |
None |
1.000 |
4 |
|
2011 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.040 |
None |
1.000 |
4 |
|
2014 |
2019 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.030 |
None |
1.000 |
3 |
|
2010 |
2014 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2018 |
Histiocytosis, Langerhans-Cell
|
disease |
Respiratory Tract Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
104
|
12
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2015 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2018 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2015 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2011 |
CONE DYSTROPHY, X-LINKED, 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Disease or Syndrome
|
10
|
9
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Fibrolamellar Hepatocellular Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
46
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
470
|
19
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Advanced Melanoma
|
disease |
|
Neoplastic Process
|
73
|
5
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Childhood Testicular Germ Cell Tumor
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
55
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Spots on skin
|
phenotype |
Skin and Connective Tissue Diseases
|
Sign or Symptom
|
43
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Primary cholangiocarcinoma of intrahepatic biliary tract
|
disease |
Neoplasms
|
Neoplastic Process
|
274
|
10
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Adult Langerhans Cell Histiocytosis
|
disease |
Respiratory Tract Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
40
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Testicular Germ Cell Tumor
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
208
|
93
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Childhood Langerhans Cell Histiocytosis
|
disease |
Respiratory Tract Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
40
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |